<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
The long-term impact of an antimicrobial stewardship program in febrile neutropenia: an 8 years follow up

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,
Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
GRADUATE SCHOOL OF HEALTH SCIENCES
Upper Org Unit
Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Ferhanoglu, Burhan

Mandel, Nil M.

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Purpose To describe the long-term effects of an ASP among febrile neutropenia (FN) patients. Methods A quasi-experimental study was conducted between 2015 and 2023 at a tertiary care hospital in Istanbul, Turkiye. The ASP was implemented for FN patients, and the effects were assessed before and after the ASP interventions, which included FN clinical pathways and regular multi-disciplinary meetings with relevant healthcare workers. Results A total of 489 FN episodes of 290 patients were included, 42% were female, and the mean age was 56 years (SD: 15, range: 18-89 years). After the intervention, the rate of appropriate antimicrobial therapy at the levels of starting (p p = 0.005), switching (p p < 0.001), and de-escalation/discontinuation, (p p < 0.001) significantly increased. Another positive impact of the ASP was a significant reduction in candidemia (from 4.88 to 0.74, p = 0.004), as well as a significant reduction in the 90-day mortality rate (from 19 to 5%, p < 0.001). In multivariate analysis, having a gram-negative bloodstream infection, prolonged days with fever, and a high risk for neutropenia were found to be significant predictors of 90-day mortality, while follow-up with ASP significantly reduced mortality. Conclusion Implementation of ASP led to reduced candidemia and LOS without increasing mortality, even in a country with a high rate of antimicrobial resistance. Implementation of sustainable ASP for FN patients is critical in combating antimicrobial resistance.

Source

Publisher

Springer

Citation

item.page.haspartof

Source

European Journal of Clinical Microbiology and Infectious Diseases

item.page.ispartofseries

item.page.edition

DOI

10.1007/s10096-024-04939-z

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators